{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T15:28:40Z","timestamp":1786375720879,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The chances of oral squamous cell carcinoma (OSCC) being diagnosed at an early stage are very low, and this leads to a poor prognosis. The presence of circulating miRNAs (miRNAs) in blood or saliva is now a potential non-invasive diagnostic biomarker, although the diagnostic accuracy of the studies reported remains vastly different due to differences in biofluids, miRNA panels, disease spectrum, and platforms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We did a meta-analysis of diagnostic accuracy and a systematic review in accordance with PRISMA-DTA 2020 guidelines (PROSPERO: CRD420251274288). Articles that evaluated circulating miRNAs in any biofluid in diagnosing OSCC were taken into consideration. A Bayesian bivariate random-effects model was used to pool together the sensitivity, specificity, likelihood ratios, diagnostic odds ratios and the summary receiver operating characteristic (sROC) curves. Heterogeneity sources were analyzed using pre-constructed subgroup analysis and meta-regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The number of studies that were evaluated in totality was seventeen and seven were incorporated in the meta-analysis. The pooled\n                      <jats:italic>sensitivity<\/jats:italic>\n                      of the circulating miRNAs towards the detection of OSCC was\n                      <jats:italic>0.89 (95% CI: 0.77\u20130.95)<\/jats:italic>\n                      and the pooled\n                      <jats:italic>specificity<\/jats:italic>\n                      was\n                      <jats:italic>0.88 (95% CI: 0.75\u20130.95)<\/jats:italic>\n                      . It had a pooled positive likelihood ratio\n                      <jats:italic>(PLR)<\/jats:italic>\n                      of\n                      <jats:italic>7.25 (95% CI: 3.42\u201316.08)<\/jats:italic>\n                      , a negative likelihood ratio\n                      <jats:italic>(NLR)<\/jats:italic>\n                      of\n                      <jats:italic>0.13<\/jats:italic>\n                      <jats:italic>(95% CI: 0.05\u20130.27)<\/jats:italic>\n                      , and a diagnostic odds ratio\n                      <jats:italic>(DOR)<\/jats:italic>\n                      of\n                      <jats:italic>59.69<\/jats:italic>\n                      <jats:italic>(95%<\/jats:italic>\n                      <jats:italic>CI:<\/jats:italic>\n                      <jats:italic>14.33-209.95)<\/jats:italic>\n                      . Good performance in discriminating was also noted in the sROC curve with an area under the curve value of approximately 0.90. However, substantial between-study heterogeneity was observed (\u03c4\u2009\u2248\u20090.93 for sensitivity; \u03c4\u2009\u2248\u20090.83 for specificity), and the 95% credible intervals around the DOR were wide (14.33\u2013209.95). Individual studies of multi-miRNA panels reported AUCs up to 0.98, though pooled subgroup estimates were limited by small study numbers and wide uncertainty.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Circulating miRNAs and in particular multi-miRNA saliva-based profiles provide promising but heterogenous diagnostic accuracy for OSCC. While individual panel studies have reported high AUCs, the current pooled evidence\u2014derived from only seven small, mostly case-control studies of advanced-stage disease\u2014does not yet establish utility for true early detection or population screening.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43046-026-00393-4","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:42:50Z","timestamp":1786372970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating microRNAs: a new era in early detection of oral squamous cell carcinoma (OSCC) \u2014 a systematic review and meta-analysis"],"prefix":"10.1186","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5132-1545","authenticated-orcid":false,"given":"Roshan Mustafa","family":"Pathan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6175-1703","authenticated-orcid":false,"given":"Umadevi","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1566-2609","authenticated-orcid":false,"given":"Jugraj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6831-1358","authenticated-orcid":false,"given":"Venkata Chandana Heshma","family":"Anumalasetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4850-0595","authenticated-orcid":false,"given":"Mukesh Ram Kumar","family":"Kommu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1677-3107","authenticated-orcid":false,"given":"Vamsi Krishna","family":"Kondepati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7555-4365","authenticated-orcid":false,"given":"Ponni Gayatri Twinkle","family":"Bade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"393_CR1","doi-asserted-by":"publisher","first-page":"7298","DOI":"10.1038\/s41598-021-86316-w","volume":"11","author":"C Rajan","year":"2021","unstructured":"Rajan C, Roshan VGD, Khan I, et al. MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma. Sci Rep. 2021;11:7298. https:\/\/doi.org\/10.1038\/s41598-021-86316-w.","journal-title":"Sci Rep"},{"issue":"6586","key":"393_CR2","doi-asserted-by":"publisher","first-page":"eaay9040","DOI":"10.1126\/science.aay9040","volume":"375","author":"D Crosby","year":"2022","unstructured":"Crosby D, Bhatia S, Brindle KM, Coussens LM, Dive C, Emberton M, Esener S, Fitzgerald RC, Gambhir SS, Kuhn P, Rebbeck TR, Balasubramanian S. Early detection of cancer. Science. 2022;375(6586):eaay9040. https:\/\/doi.org\/10.1126\/science.aay9040.","journal-title":"Science"},{"issue":"10","key":"393_CR3","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jamadermatol.2022.3628","volume":"158","author":"VD Ching-Roa","year":"2022","unstructured":"Ching-Roa VD, Huang CZ, Ibrahim SF, Smoller BR, Giacomelli MG. Real-time analysis of skin biopsy specimens with 2-photon fluorescence microscopy. JAMA Dermatol. 2022;158(10):1175\u201382. https:\/\/doi.org\/10.1001\/jamadermatol.2022.3628.","journal-title":"JAMA Dermatol"},{"key":"393_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1758-3284-3-39","volume":"3","author":"R Mehrotra","year":"2011","unstructured":"Mehrotra R, Mishra S, Singh M, Singh M. The efficacy of oral brush biopsy with computer-assisted analysis in identifying precancerous and cancerous lesions. Head Neck Oncol. 2011;3:39. https:\/\/doi.org\/10.1186\/1758-3284-3-39.","journal-title":"Head Neck Oncol"},{"issue":"10","key":"393_CR5","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3390\/biomedicines9101478","volume":"9","author":"E P\u00e9rez-Ruiz","year":"2021","unstructured":"P\u00e9rez-Ruiz E, Guti\u00e9rrez V, Mu\u00f1oz M, Oliver J, S\u00e1nchez M, G\u00e1lvez-Carvajal L, Rueda-Dom\u00ednguez A, Barrag\u00e1n I. Liquid biopsy as a tool for the characterisation and early detection of the field cancerization effect in patients with oral cavity carcinoma. Biomedicines. 2021;9(10):1478. https:\/\/doi.org\/10.3390\/biomedicines9101478.","journal-title":"Biomedicines"},{"issue":"2","key":"393_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1515\/bmc-2017-0002","volume":"8","author":"V Armand-Labit","year":"2017","unstructured":"Armand-Labit V, Pradines A. Circulating cell-free microRNAs as clinical cancer biomarkers. Biomol Concepts. 2017;8(2):61\u201381. https:\/\/doi.org\/10.1515\/bmc-2017-0002.","journal-title":"Biomol Concepts"},{"key":"393_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41416-021-01672-8","volume":"126","author":"S Toden","year":"2022","unstructured":"Toden S, Goel A. Non-coding RNAs as liquid biopsy biomarkers in cancer. Br J Cancer. 2022;126:351\u201360. https:\/\/doi.org\/10.1038\/s41416-021-01672-8.","journal-title":"Br J Cancer"},{"key":"393_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canep.2018.12.008","volume":"58","author":"S Mazumder","year":"2019","unstructured":"Mazumder S, Datta S, Ray JG, Chaudhuri K, Chatterjee R. Liquid biopsy: miRNA as a potential biomarker in oral cancer. Cancer Epidemiol. 2019;58:137\u201345. https:\/\/doi.org\/10.1016\/j.canep.2018.12.008.","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"393_CR9","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.21873\/invivo.12048","volume":"34","author":"S Ueda","year":"2020","unstructured":"Ueda S, Hashimoto K, Miyabe S, Hasegawa S, Goto M, Shimizu D, Oh-Iwa I, Shimozato K, Nagao T, Nomoto S. Salivary NUS1 and RCN1 levels as biomarkers for oral squamous cell carcinoma diagnosis. Vivo. 2020;34(5):2353\u201361. https:\/\/doi.org\/10.21873\/invivo.12048.","journal-title":"Vivo"},{"key":"393_CR10","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.3390\/genes13101874","volume":"13","author":"R Sullivan","year":"2022","unstructured":"Sullivan R, Montgomery A, Scipioni A, Jhaveri P, Schmidt AT, Hicks SD. Confounding factors impacting microRNA expression in human saliva: methodological and biological considerations. Genes. 2022;13:1874. https:\/\/doi.org\/10.3390\/genes13101874.","journal-title":"Genes"},{"issue":"6","key":"393_CR11","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.7150\/thno.45157","volume":"11","author":"C Romani","year":"2021","unstructured":"Romani C, Salviato E, Paderno A, Zanotti L, Ravaggi A, Deganello A, Berretti G, Gualtieri T, Marchini S, D\u2019Incalci M, Mattavelli D, Piazza C, Bossi P, Romualdi C, Nicolai P, Bignotti E. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma. Theranostics. 2021;11(6):2987\u201399. https:\/\/doi.org\/10.7150\/thno.45157.","journal-title":"Theranostics"},{"key":"393_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41368-023-00273-w","volume":"16","author":"J Balakittnen","year":"2024","unstructured":"Balakittnen J, Ekanayake Weeramange C, Wallace DF, et al. A novel saliva-based miRNA profile to diagnose and predict oral cancer. Int J Oral Sci. 2024;16:14. https:\/\/doi.org\/10.1038\/s41368-023-00273-w.","journal-title":"Int J Oral Sci"},{"issue":"3","key":"393_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3233\/CBM-181265","volume":"23","author":"L Chen","year":"2018","unstructured":"Chen L, Hu J, Pan L, Yin X, Wang Q, Chen H. Diagnostic and prognostic value of serum miR-99a expression in oral squamous cell carcinoma. Cancer Biomark. 2018;23(3):333\u20139. https:\/\/doi.org\/10.3233\/CBM-181265.","journal-title":"Cancer Biomark"},{"key":"393_CR14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1186\/s12903-023-03726-0","volume":"23","author":"NAF Tarrad","year":"2023","unstructured":"Tarrad NAF, Hassan S, Shaker OG, et al. Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma: an observational diagnostic study. BMC Oral Health. 2023;23:994. https:\/\/doi.org\/10.1186\/s12903-023-03726-0.","journal-title":"BMC Oral Health"},{"key":"393_CR15","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s12105-023-01600-7","volume":"17","author":"A Garg","year":"2023","unstructured":"Garg A, Urs AB, Koner BC, et al. Evaluation of diagnostic significance of salivary miRNA-184 and miRNA-21 in oral squamous cell carcinoma and oral potentially malignant disorders. Head Neck Pathol. 2023;17:961\u20138. https:\/\/doi.org\/10.1007\/s12105-023-01600-7.","journal-title":"Head Neck Pathol"},{"key":"393_CR16","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3390\/biology9110379","volume":"9","author":"S Crimi","year":"2020","unstructured":"Crimi S, Falzone L, Gattuso G, Grillo CM, Candido S, Bianchi A, Libra M. Droplet digital PCR analysis of liquid biopsy samples unveils the diagnostic role of hsa-miR-133a-3p and hsa-miR-375-3p in oral cancer. Biology (Basel). 2020;9:379. https:\/\/doi.org\/10.3390\/biology9110379.","journal-title":"Biology (Basel)"},{"key":"393_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41405-024-00278-5","volume":"10","author":"MM El Hefny","year":"2024","unstructured":"El Hefny MM, Korien IA, Rashwan WAM, Shaker OG. The oncogenic potential of salivary microRNA-93 and microRNA-412-3p in oral lichen planus: a case-control study. BDJ Open. 2024;10:98. https:\/\/doi.org\/10.1038\/s41405-024-00278-5.","journal-title":"BDJ Open"},{"issue":"7","key":"393_CR18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3390\/diagnostics13071244","volume":"13","author":"A Garajei","year":"2023","unstructured":"Garajei A, Allameh A, Azadi M, Emami A, Atashbasteh M, Mostafavi M, Ghaderi B, Inchingolo F, Sadeghi M, Tadakamadla SK, Mohammadi H, Tadakamadla J. Evaluation of the expression levels of miR-21-5p and miR-429 genes in biopsy samples from patients with oral squamous cell carcinoma. Diagnostics (Basel). 2023;13(7):1244. https:\/\/doi.org\/10.3390\/diagnostics13071244.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"393_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4103\/jomfp.jomfp_360_20","volume":"25","author":"NS Priya","year":"2021","unstructured":"Priya NS, Nayak R, Bhat K, Kugaji M, Vijayalakshmi K, Rao K. Site specificity and expression profile of miR-21 in oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2021;25(1):154\u20138. https:\/\/doi.org\/10.4103\/jomfp.jomfp_360_20.","journal-title":"J Oral Maxillofac Pathol"},{"issue":"12","key":"393_CR20","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1158\/1055-9965.EPI-22-0376","volume":"31","author":"R Pastorino","year":"2022","unstructured":"Pastorino R, Sassano M, Danilo Tiziano F, Giraldi L, Amore R, Arzani D, Abiusi E, Ahrens W, Vilches LA, Canova C, Healy CM, Holcatova I, Lagiou P, Polesel J, Popovic M, Nyg\u00e5rd S, Cadoni G, Znaor A, Boffetta P, Matsuo K, Oze I, Brennan P, Boccia S. Plasma miR-151-3p as a candidate diagnostic biomarker for head and neck cancer: a cross-sectional study within the INHANCE Consortium. Cancer Epidemiol Biomarkers Prev. 2022;31(12):2237\u201343. https:\/\/doi.org\/10.1158\/1055-9965.EPI-22-0376.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"393_CR21","doi-asserted-by":"publisher","first-page":"456","DOI":"10.61186\/rbmb.13.4.456","volume":"13","author":"S Seyedhoseini","year":"2025","unstructured":"Seyedhoseini S, Mohtasham N, Saghafi S, Alahkhani N, Mohajertehran F, Afzaljavan F, Shakeri MT, Bokharaei A. miR-let-7a differential expression in oral squamous cell carcinoma and oral lichen planus: insights for early diagnostic biomarker development. Rep Biochem Mol Biol. 2025;13(4):456\u201365. https:\/\/doi.org\/10.61186\/rbmb.13.4.456.","journal-title":"Rep Biochem Mol Biol"},{"issue":"2","key":"393_CR22","doi-asserted-by":"publisher","first-page":"244","DOI":"10.30699\/IJP.2024.2010130.3161","volume":"19","author":"S Bagheri Shirvan","year":"2024","unstructured":"Bagheri Shirvan S, Shahabinejad M, Mohajertehran F, Nazari N. Evaluation of miR-1290 as a possible diagnostic factor in the serum of oral squamous cell carcinoma patients using qualitative real-time polymerase chain reaction. Iran J Pathol. 2024;19(2):244\u20139. https:\/\/doi.org\/10.30699\/IJP.2024.2010130.3161.","journal-title":"Iran J Pathol"},{"key":"393_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5125\/jkaoms.2020.46.5.341","volume":"46","author":"N Emami","year":"2020","unstructured":"Emami N, Mohamadnia A, Mirzaei M, Bayat M, Mohammadi F, Bahrami N. miR-155, miR-191, and miR-494 as diagnostic biomarkers for oral squamous cell carcinoma and the effects of Avastin on these biomarkers. J Korean Assoc Oral Maxillofac Surg. 2020;46:341\u20137. https:\/\/doi.org\/10.5125\/jkaoms.2020.46.5.341.","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"393_CR24","doi-asserted-by":"publisher","first-page":"971596","DOI":"10.3389\/fcell.2022.971596","volume":"10","author":"L Hofmann","year":"2022","unstructured":"Hofmann L, Abou Kors T, Ezi\u0107 J, Niesler B, R\u00f6th R, Ludwig S, Laban S, Schuler PJ, Hoffmann TK, Brunner C, Medyany V, Theodoraki MN. Comparison of plasma- and saliva-derived exosomal miRNA profiles reveals diagnostic potential in head and neck cancer. Front Cell Dev Biol. 2022;10:971596. https:\/\/doi.org\/10.3389\/fcell.2022.971596.","journal-title":"Front Cell Dev Biol"},{"key":"393_CR25","doi-asserted-by":"publisher","first-page":"907219","DOI":"10.3389\/fgene.2022.907219","volume":"13","author":"L Jia","year":"2022","unstructured":"Jia L, Huang P, Lin T, Lin C, Ding X, Lin L, Zhu L, Zhou Z. CircPUM1 knockdown confers radiosensitivity in oral squamous cell carcinoma by regulating the miR-580\/STAT3 pathway. Front Genet. 2022;13:907219. https:\/\/doi.org\/10.3389\/fgene.2022.907219.","journal-title":"Front Genet"},{"issue":"9","key":"393_CR26","doi-asserted-by":"publisher","first-page":"6931","DOI":"10.18632\/oncotarget.3165","volume":"6","author":"G Zheng","year":"2015","unstructured":"Zheng G, Jia X, Peng C, Deng Y, Yin J, Zhang Z, Li N, Deng M, Liu X, Liu H, Lu M, Wang C, Gu Y, He Z. The miR-491-3p\/mTORC2\/FOXO1 regulatory loop modulates chemo-sensitivity in human tongue cancer. Oncotarget. 2015;6(9):6931\u201343. https:\/\/doi.org\/10.18632\/oncotarget.3165.","journal-title":"Oncotarget"},{"key":"393_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13036-025-00492-1","volume":"19","author":"SN Nagdeve","year":"2025","unstructured":"Nagdeve SN, Suganthan B, Ramasamy RP. An electrochemical biosensor for the detection of microRNA-31 as a potential oral cancer biomarker. J Biol Eng. 2025;19:24. https:\/\/doi.org\/10.1186\/s13036-025-00492-1.","journal-title":"J Biol Eng"},{"key":"393_CR28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1186\/s40001-025-03003-6","volume":"30","author":"S Zafar","year":"2025","unstructured":"Zafar S, Hafeez A, Shah H, et al. Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives. Eur J Med Res. 2025;30:760. https:\/\/doi.org\/10.1186\/s40001-025-03003-6.","journal-title":"Eur J Med Res"},{"key":"393_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/978-1-62703-083-0_24","volume-title":"MicroRNA protocols. Methods in Molecular Biology","author":"JM Yoshizawa","year":"2013","unstructured":"Yoshizawa JM, Wong DTW. Salivary microRNAs and oral cancer detection. In: Ying SY, editor. MicroRNA protocols. Methods in Molecular Biology. Volume 936. Totowa (NJ): Humana; 2013. pp. 313\u201324. https:\/\/doi.org\/10.1007\/978-1-62703-083-0_24."},{"key":"393_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/SCRR.1000103","volume":"1","author":"F Ahmed","year":"2017","unstructured":"Ahmed F, Ahmed N, Gouda M, Vos P. miRNAs for the diagnostic screening of early stages of colon cancer in stool or blood. Surg Case Rep Rev. 2017;1:1\u201319. https:\/\/doi.org\/10.15761\/SCRR.1000103.","journal-title":"Surg Case Rep Rev"},{"issue":"1","key":"393_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/14737159.2017.1404906","volume":"18","author":"LMRB Arantes","year":"2018","unstructured":"Arantes LMRB, De Carvalho AC, Melendez ME, Lopes Carvalho A. Serum, plasma and saliva biomarkers for head and neck cancer. Expert Rev Mol Diagn. 2018;18(1):85\u2013112. https:\/\/doi.org\/10.1080\/14737159.2017.1404906.","journal-title":"Expert Rev Mol Diagn"},{"key":"393_CR32","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/biomedicines11030965","volume":"11","author":"A Roi","year":"2023","unstructured":"Roi A, Boia S, Rusu LC, Roi CI, Boia ER, Rivi\u0219 M. Circulating miRNA as a biomarker in oral cancer liquid biopsy. Biomedicines. 2023;11:965. https:\/\/doi.org\/10.3390\/biomedicines11030965.","journal-title":"Biomedicines"},{"key":"393_CR33","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","volume":"43","author":"GAD Metcalf","year":"2024","unstructured":"Metcalf GAD. MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances. Oncogene. 2024;43:2135\u201342. https:\/\/doi.org\/10.1038\/s41388-024-03076-3.","journal-title":"Oncogene"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00393-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-026-00393-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-026-00393-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:42:51Z","timestamp":1786372971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43046-026-00393-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["393"],"URL":"https:\/\/doi.org\/10.1186\/s43046-026-00393-4","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This study is a systematic review and diagnostic meta-analysis based exclusively on previously published data. No new human participants were enrolled, and therefore ethical approval and informed consent were not required. The review protocol was prospectively registered in the International Prospective Register of Systematic Reviews (PROSPERO) under registration number\n                      CRD420251274288\n                      and was conducted in accordance with the PRISMA guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"55"}}